Antiviral Agents Concept

subject area of

• 5-(Perylen-3-yl)Ethynyl-arabino-Uridine (aUY11), an Arabino-Based Rigid Amphipathic Fusion Inhibitor, Targets Virion Envelope Lipids To Inhibit Fusion of Influenza Virus, Hepatitis C Virus, and Other Enveloped Viruses  Academic Article
• cTAZ : a safeguard factor of antiviral response  Academic Article
• A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial  Academic Article
• A Comparison of Respiratory Syncytial Viral Prophylaxis in Multiple Births versus Singletons in the Canadian Registry of Palivizumab  Academic Article
• A Controlled Trial of Oral Acyclovir for Iridocyclitis Caused by Herpes Simplex Virus  Academic Article
• A Decade of Respiratory Syncytial Virus Epidemiology and Prophylaxis: Translating Evidence into Everyday Clinical Practice  Academic Article
• A Survey of Parental Knowledge of Respiratory Syncytial Virus and Other Respiratory Infections in Preterm Infants  Academic Article
• A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)  Academic Article
• A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection  Academic Article
• A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders  Academic Article
• A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)  Academic Article
• A real-time dashboard of clinical trials for COVID-19  Academic Article
• A review of cost–effectiveness of palivizumab for respiratory syncytial virus  Academic Article
• Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19  Academic Article
• Activation and Inhibition of Virus and Interferon: The Herpesvirus Story  Academic Article
• Acyclovir Prophylaxis to Prevent Herpes Simplex Virus Recurrence at Delivery: A Systematic Review  Academic Article
• Adaptive immune responses fail to provide protection against genital HSV-2 infection in the absence of IL-15  Academic Article
• Adherence and outcomes: a systematic review of palivizumab utilization  Academic Article
• Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab  Academic Article
• Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants  Academic Article
• Adverse Effects of Amantadine and Oseltamivir Used During Respiratory Outbreaks in a Center for Developmentally Disabled Adults  Academic Article
• Adverse Events Associated with High-Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome  Academic Article
• An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutionalized patients.  Academic Article
• Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation  Academic Article
• Anti-Ebola therapy for patients with Ebola virus disease: a systematic review  Academic Article
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial  Academic Article
• Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis  Academic Article
• Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2  Academic Article
• Antiviral Agents for Influenza  Academic Article
• Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis  Academic Article
• Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus  Academic Article
• Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC⁴E): the ALIC⁴E protocol  Academic Article
• Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies  Academic Article
• Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies  Academic Article
• Atypical clinical course in juvenile metachromatic leukodystrophy involving novel arylsulfatase A gene mutations  Academic Article
• Burden of respiratory syncytial virus hospitalisation among infants born at 32–35 weeks' gestational age in the Northern Hemisphere: pooled analysis of seven studies  Academic Article
• CARESS  Academic Article
• CARESS: The Canadian Registry of Palivizumab  Academic Article
• Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries  Academic Article
• Changing costs and the impact on RSV prophylaxis  Academic Article
• Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2  Academic Article
• Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis  Academic Article
• Cigarette Smoke Suppresses Type I Interferon-Mediated Antiviral Immunity in Lung Fibroblast and Epithelial Cells  Academic Article
• Cigarette smoke attenuation of poly I:C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-β production  Academic Article
• Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome  Academic Article
• Clinical course of acute infection of the upper respiratory tract in children: cohort study  Academic Article
• Clinical features of external genital warts.  Academic Article
• Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin  Academic Article
• Combined Corticosteroid and Antiviral Treatment for Bell Palsy  Academic Article
• Community-acquired pneumonia: An overview  Academic Article
• Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005–2015)  Academic Article
• Comparison of the Cost of Hospitalization for Respiratory Syncytial Virus Disease Versus Palivizumab Prophylaxis in Canadian Inuit Infants  Academic Article
• Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with model phospholipid membranes  Academic Article
• Comparison of three cell-based drug screening platforms for HSV-1 infection  Academic Article
• Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada  Academic Article
• Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada  Academic Article
• Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey.  Academic Article
• Countermeasures against viral diseases of farmed fish  Academic Article
• Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico  Academic Article
• Current strategies in the prevention of respiratory syncytial virus disease  Academic Article
• Cytomegalovirus infection of a cutaneous ulcer in a patient with ANCA-positive vasculitis  Academic Article
• Deep learning identifies synergistic drug combinations for treating COVID-19  Academic Article
• Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses  Academic Article
• Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial  Academic Article
• Direct anterior approach and dual mobility cup: the “head-first” reduction technique: a technical note and early case series  Academic Article
• Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis  Academic Article
• Discovery and Use of Long dsRNA Mediated RNA Interference to Stimulate Antiviral Protection in Interferon Competent Mammalian Cells  Academic Article
• Discovery of potent antiviral (HSV-1) quinazolinones and initial structure-activity relationship studies  Academic Article
• Diversity-Oriented Synthesis and Preliminary Biological Screening of Highly Substituted Five-Membered Lactones and Lactams Originating From an Allyboration of Aldehydes and Imines  Academic Article
• Do Antiviral Medications Improve Symptoms in the Treatment of Bell’s Palsy?  Academic Article
• Do Either Corticosteroids or Antiviral Agents Reduce the Risk of Long-Term Facial Paresis in Patients with New-Onset Bell's Palsy?  Academic Article
• Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis  Academic Article
• Does prophylaxis with palivizumab reduce hospitalisation rates for respiratory-syncytial-virus-related infection in cystic fibrosis children less than 2 years of age?  Academic Article
• Drug treatments for covid-19: living systematic review and network meta-analysis  Academic Article
• Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient  Academic Article
• Early Treatment with Pegylated Interferon Lambda for Covid-19  Academic Article
• Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs  Academic Article
• Ebola Virus in West Africa: Waiting for the Owl of Minerva  Academic Article
• Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19  Academic Article
• Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine.  Academic Article
• Efficacité et innocuité des agents antiviraux contre le SRAS-CoV-2, selon des données d’études sur la COVID-19 et d’autres infections virales aiguës : revue systématique et méta-analyse  Academic Article
• Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis  Academic Article
• Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6  Academic Article
• Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis  Academic Article
• Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials  Academic Article
• Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial  Academic Article
• Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus  Academic Article
• Encephalitis  Academic Article
• Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS  Academic Article
• Expert consensus on palivizumab use for respiratory syncytial virus in developed countries  Academic Article
• Exploring respiratory syncytial virus prophylaxis for children with all grades of bronchopulmonary dysplasia  Academic Article
• Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals  Academic Article
• Filamentous Phages as Building Blocks for Bioactive Hydrogels  Academic Article
• First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005–2015)  Academic Article
• Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders  Academic Article
• Global molecular diversity of RSV – the “INFORM RSV” study  Academic Article
• Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts  Academic Article
• Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression  Academic Article
• Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society  Academic Article
• Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis  Academic Article
• Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention  Academic Article
• Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants  Academic Article
• Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon  Academic Article
• Herpes Simplex Virus ICP0 and ICP34.5 Counteract Distinct Interferon-Induced Barriers to Virus Replication  Academic Article
• Herpes Zoster: Diagnostic, Therapeutic, and Preventive Approaches  Academic Article
• High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention  Academic Article
• High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase  Academic Article
• High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments  Academic Article
• Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study  Academic Article
• Hospitalization for Respiratory Syncytial Virus Illness in Down Syndrome Following Prophylaxis With Palivizumab  Academic Article
• How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?  Academic Article
• How much management is necessary? Sustaining the benefit of achieving a sustained virologic response to hepatitis C  Academic Article
• Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19  Academic Article
• IFN-γ treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes  Academic Article
• IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling  Academic Article
• Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes  Academic Article
• Identification of a Novel Pathway Essential for the Immediate-Early, Interferon-Independent Antiviral Response to Enveloped Virions  Academic Article
• Identifying and Ensuring Optimal Care for All Children at Risk of Developing Serious Respiratory Syncytial Virus Disease: A Canadian Nurses’ Perspective  Academic Article
• Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness  Academic Article
• Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C  Academic Article
• Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada  Academic Article
• Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS  Academic Article
• Induction of Innate Immune Responses in the Female Genital Tract: Friend or Foe of HIV-1 Infection?  Academic Article
• Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report  Academic Article
• Influenza Promotes Collagen Deposition via αvβ6 Integrin-mediated Transforming Growth Factor β Activation  Academic Article
• Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers  Academic Article
• Inhibition of Warfarin Activity by Ribavirin  Academic Article
• Interferon-β induced in female genital epithelium by HIV-1 glycoprotein 120 via Toll-like-receptor 2 pathway acts to protect the mucosal barrier  Academic Article
• Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)  Academic Article
• Isolation and Characterization of Novel Marine-Derived Actinomycete Taxa Rich in Bioactive Metabolites  Academic Article
• Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group  Academic Article
• Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study  Academic Article
• Letter to the Editor  Academic Article
• Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort  Academic Article
• Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2  Academic Article
• Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon  Academic Article
• Management of Bell palsy: clinical practice guideline  Academic Article
• Managing drug shortages during a pandemic: tocilizumab and COVID-19  Academic Article
• Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes  Academic Article
• Massive air leak secondary to influenza B in a 7-year-old: A case report  Academic Article
• Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future  Academic Article
• Mood disorder associated with gastrointestinal and liver diseases: are there many challenges?  Academic Article
• My Kingdom for a Denominator, or at Least Enough Data  Academic Article
• NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection  Academic Article
• Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection  Academic Article
• Novel therapy for asthma  Academic Article
• ORAL VALACYCLOVIR IN THE TREATMENT OF ACUTE RETINAL NECROSIS SYNDROME  Academic Article
• On the mechanism of inhibition of viral and vesicle membrane fusion by carbobenzoxy-D-phenylalanyl-L-phenylalanylglycine  Academic Article
• Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care  Academic Article
• Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada  Academic Article
• Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018  Academic Article
• Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial  Academic Article
• Oseltamivir use amongst hospitalized patients infected with influenza  Academic Article
• Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada)  Academic Article
• Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy  Academic Article
• Outpatient Treatment of Confirmed COVID-19: Living, Rapid Practice Points From the American College of Physicians (Version 1)  Academic Article
• Palivizumab Adherence and Outcomes in Canadian Aboriginal Children  Academic Article
• Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes  Academic Article
• Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?  Academic Article
• Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients  Academic Article
• Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic  Academic Article
• Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy  Academic Article
• Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus  Academic Article
• Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials  Academic Article
• Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C  Academic Article
• Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial  Academic Article
• Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C  Academic Article
• Peptides as potential virus inhibitors  Academic Article
• Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research  Academic Article
• Postexposure prophylaxis for common infectious diseases.  Academic Article
• Predictors of Recurrent Herpes Simplex Virus Keratitis  Academic Article
• Preemptive Strategy for Ganciclovir Administration Against Cytomegalovirus in Liver Transplantation Recipients  Academic Article
• Properties of lipoamino acids incorporated into membrane bilayers  Academic Article
• Prophylaxis for COVID-19: a systematic review  Academic Article
• Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic  Academic Article
• R430: A potent inhibitor of DNA and RNA viruses  Academic Article
• REVIEW ARTICLE: The Role of Toll-Like Receptor Ligands/Agonists in Protection Against Genital HSV-2 Infection  Academic Article
• Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies  Academic Article
• Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals  Academic Article
• Rebuttal: palivizumab for the prevention of respiratory syncytial virus infection.  Academic Article
• Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity  Academic Article
• Regulation of kynurenine biosynthesis during influenza virus infection  Academic Article
• Reliability and Validity of the HIV Disability Questionnaire (HDQ) with Adults Living with HIV in the United States  Academic Article
• Remdesivir for severe covid-19: a clinical practice guideline  Academic Article
• Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial  Academic Article
• Respiratory Syncytial Virus Immunoprophylaxis with Palivizumab: 12-Year Observational Study of Usage and Outcomes in Canada  Academic Article
• Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005–2017  Academic Article
• Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab  Academic Article
• Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations  Academic Article
• Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab  Academic Article
• Respiratory syncytial virus (RSV) infection in children with medical complexity  Academic Article
• Respiratory syncytial virus nosocomial outbreak in neonatal intensive care: A review of the incidence, management, and outcomes  Academic Article
• Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?  Academic Article
• Respiratory syncytial virus prophylaxis in children with cardiac disease: a retrospective single-centre study  Academic Article
• Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005–2016)  Academic Article
• Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders  Academic Article
• Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries  Academic Article
• Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection  Conference Paper
• Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy  Academic Article
• Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses  Academic Article
• Risk of Acute Kidney Injury From Oral Acyclovir: A Population-Based Study  Academic Article
• Risk of Cardiovascular Disease Associated with HCV and HBV Coinfection among Antiretroviral-Treated HIV-Infected Individuals  Academic Article
• Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention  Academic Article
• Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients  Academic Article
• Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry  Academic Article
• Seasonal Respiratory Syncytial Virus Prophylaxis Based on Predetermined Dates Versus Regional Surveillance Data  Academic Article
• Severe late-onset multisystem cytomegalovirus infection in a premature neonate previously treated for congenital infection  Academic Article
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1)  Academic Article
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)  Academic Article
• Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2, Update Alert 3)  Academic Article
• Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study  Conference Paper
• Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis  Academic Article
• Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update  Academic Article
• Susceptibility of Human Female Primary Genital Epithelial Cells to Herpes Simplex Virus, Type-2 and the Effect of TLR3 Ligand and Sex Hormones on Infection1  Academic Article
• Synergistic binding of inhibitors to the protease from HIV type 1  Academic Article
• Synthesis of non-nucleoside anti-viral cyclopropylcarboxacyl hydrazones and initial anti-HSV-1 structure-activity relationship studies  Academic Article
• Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease  Academic Article
• The 1−127 HA2 Construct of Influenza Virus Hemagglutinin Induces Cell−Cell Hemifusion  Academic Article
• The Genesis and Spread of Reassortment Human Influenza A/H3N2 Viruses Conferring Adamantane Resistance  Academic Article
• The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes  Academic Article
• The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19  Academic Article
• The Nitric Oxide Pathway Provides Innate Antiviral Protection in Conjunction with the Type I Interferon Pathway in Fibroblasts  Academic Article
• The Real-Life Effectiveness of Palivizumab for Reducing Hospital Admissions for Respiratory Syncytial Virus in Infants Residing in Nunavut  Academic Article
• The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19  Academic Article
• The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation  Academic Article
• The cancer patient with chronic pain due to herpes zoster  Academic Article
• The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence  Academic Article
• The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic  Academic Article
• The cost effectiveness of palivizumab: a systematic review of the evidence  Academic Article
• The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis  Academic Article
• The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials  Academic Article
• The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach  Academic Article
• The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study  Academic Article
• The learning curve for the direct anterior total hip arthroplasty: a systematic review  Academic Article
• The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect  Academic Article
• The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients  Academic Article
• Therapeutic options for external genital warts.  Academic Article
• Treatment Outcomes of Treatment-Naïve Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts  Academic Article
• Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline  Academic Article
• Treatment responses in Asians and Caucasians with chronic hepatitis C infection  Academic Article
• Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2  Academic Article
• Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)  Academic Article
• Use of Oseltamivir During Influenza Outbreaks in Ontario Nursing Homes, 1999–2000  Academic Article
• Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials  Academic Article
• Viral infections in the elderly  Academic Article
• WHO Living Guidelines on antivirals for COVID-19 are evidence-based  Academic Article
• WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus  Academic Article
• Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?  Academic Article
• Zanamivir Use During Transmission of Amantadine-Resistant Influenza A in a Nursing Home  Conference Paper